DOCTEUR MOUSTAPHA ASSAF
ActiveSummary
DOCTEUR MOUSTAPHA ASSAF has been active since 2009 and the Belgian State Gazette contains no insolvency or warning signals. The 2025 annual accounts show equity of €2.94M and a net result of €422k. Equity is growing by ~11.6% per year across the filed fiscal years. Its solvency ranks better than 95% of 637 sector peers (fiscal year 2025). The computed 12-month bankruptcy probability is 0.1% (very low).
Checked score
Score 2025
93
/ 100
Excellent
The score weighs solvency, liquidity and profitability. Bankruptcy probability contributes 35%. Every signal that weighs is under Signals.
Axes · tick = 2024
Profitability86▲+1
Solvency100▲+4
Growth78=
Track record100
Bankruptcy probability, 12 months
0.1%
Very low
0%0.5%1.5%4%10%≥ 25%
Credit up to €270k at 30 days acceptable
Liquidity ample (current ratio 29.39 against 3.42 in 2024; short-term debt: 3.3% and cash: 31.5% of total assets), and 5.2% of the assets are financed with debt.
Credit advice for your own amount and term
Signals
Six signals. The signal on the left, the evidence on the right.
−lowers risk+raises risk○neutral
lowers risk · Lower-failure-rate sector
In this sector companies fail less often than the Belgian average.
Gazette · bankruptcies per sector, NACE 86
Relative position
BE, all sectors
reference
Sector 86
lower
← fewer bankruptcies
more bankruptcies →
lowers risk · Annual accounts: healthy financial profile
The latest annual accounts show a healthy profile in solvency, result and liquidity.
NBB · annual accounts 2025Solvency, return and age of the figures
Solvency
94.8%
Return on assets
13.6%
Age of the figures
18 mo
lowers risk · Long track record
A company with a long track record statistically fails less often than a young one.
KBO · incorporation dateAge against the risk zone
neutral · Latest accounts filed on time
The financial year that closed on 31-03-2025 was due by 31-10-2025 and was filed on 30-10-2025, 1 day ahead of the deadline.
NBB · 10 filingsDeviation from the deadline
2025
1 d early
2024
1 d early
2023
4 d early
2022
32 d early
2021
23 d early
2020
1 d early
2019
2 d early
← before the deadline
after the deadline →
Checked, nothing found (2)
neutral · The next deadline is still running
The next financial year closes on 31-03-2026 and is due by 31-10-2026. Nothing is late today.
Companies Code · seven monthsPosition in the running window
31-03-2026 close24-09-2026 today31-10-2026 deadline
Financials · fiscal year 2025, full schema
Turnover
Not included in this filing
EBIT margin
Not included in this filing
Net result
€422k▼ 7.8%
2024 · €458k
2019: €310k
2020: €291k
2021: €454k
2022: €514k
2023: €461k
2024: €458k
2019 → 2025
Working capital
€2.94M▲ 20.1%
2024 · €2.45M
2019: €1.30M
2020: €1.63M
2021: €1.95M
2022: €2.44M
2023: €2.88M
2024: €2.45M
2019 → 2025
Multi-year overview
Every figure with its change against the year before
▲ rise
▼ fall
Line20212022202320242025Trend
Equity€2.00M-€2.51M▲ 25.7%€2.97M▲ 18.3%€2.52M▼ 15.2%€2.94M▲ 16.8%
Operating result€592k-€732k▲ 23.7%€671k▼ 8.3%€658k▼ 2.0%€558k▼ 15.2%
Net result€454k-€514k▲ 13.3%€461k▼ 10.4%€458k▼ 0.6%€422k▼ 7.8%
Result per fiscal year
Operating resultNet result
The operating result has fallen three years in a row; 2025 is 15% below 2024 and is the lowest result in the available series.
Balance-sheet composition
2025 in colour, 2024 as the grey bar beneath
Assets €3.10M
Fixed assets
€64k ▼ 18.5%
Current assets
€3.04M ▼ 12.0%
Equity and liabilities €3.10M
Equity
€2.94M ▲ 16.8%
Debt
€160k ▼ 84.2%
Debt's share of the balance-sheet total falls from 28.7% to 5.2%. Equity is higher and debt is lower.
Key figures and ratios
EBITDA
€579k▼
2024 · €681k
Cash flow
€444k▼
2024 · €481k
Current ratio
29.39▲
2024 · 3.42
Debt to equity
0.05▼
2024 · 0.40
ROE
14.3%▼
2024 · 18.2%
ROA
13.6%▲
2024 · 13.0%
Interest coverage
111.26▲
2024 · 93.15
Debt ≤ 1 year
€103k▼
2024 · €1.01M
Income taxes
€187k▼
2024 · €210k
Staff costs
€109k▲
2024 · €90k
Green means a favourable move, even when the figure itself falls: as with debt or debt to equity.
Filed annual accounts As filed with the NBB · 2025 against 2024 · 50 lines
Balance sheet
Code20242025
Assets
Total assets20/58€3.53M€3.10M▼
Fixed assets21/28€79k€64k▼
Intangible fixed assets21€0€0=
Tangible fixed assets22/27€79k€64k▼
Plant, machinery and equipment23€8k€7k▼
Furniture and vehicles24€24k€17k▼
Other tangible fixed assets26€47k€40k▼
Current assets29/58€3.46M€3.04M▼
Amounts receivable within one year40/41€701€4▼
Trade receivables40€701€4▼
Current investments50/53€1.41M€2.02M▲
Cash at bank and in hand54/58€1.99M€978k▼
Deferred charges and accrued income490/1€64k€47k▼
Equity and liabilities
Total equity and liabilities10/49€3.53M€3.10M▼
Equity10/15€2.52M€2.94M▲
Contributions10/11€19k€19k=
Reserves13€2.50M€2.93M▲
Non-distributable reserves130/1€9k€9k=
Reserves not available under the articles1311€9k€9k=
Tax-exempt reserves132€445€445=
Distributable reserves133€2.49M€2.92M▲
Amounts payable17/49€1.01M€160k▼
Amounts payable within one year42/48€1.01M€103k▼
Trade debts44€7k€7k▼
Suppliers440/4€7k€7k▼
Taxes, remuneration and social security45€53k€19k▼
Taxes450/3€45k€5k▼
Remuneration and social security454/9€8k€14k▲
Other amounts payable47/48€951k€78k▼
Accrued charges and deferred income492/3€3k€57k▲
Income statement
Code20242025
Remuneration, social security and pensions62€90k€109k▲
Depreciation of and write-downs on formation expenses, intangible and tangible fixed assets630€23k€21k▼
Other operating charges640/8€3k€3k▲
Gross operating margin9900€775k€691k▼
Operating profit (loss)9901€658k€558k▼
Financial income75/76B€18k€57k▲
Recurring financial income75€18k€57k▲
Financial charges65/66B€7k€5k▼
Recurring financial charges65€7k€5k▼
Profit (loss) for the period before taxes9903€668k€609k▼
Income taxes67/77€210k€187k▼
Profit (loss) for the period9904€458k€422k▼
Profit (loss) for the period to be appropriated9905€458k€422k▼
Appropriation of the result
Profit (loss) to be appropriated9906€458k€422k▼
Transfer from equity791/2€910k-
Transfer to equity691/2€458k€422k▼
To other reserves6921€458k€422k▼
Profit to be distributed694/7€910k-
Return on contributions (dividend)694€910k-
Social balance
Average headcount (FTE)90873.52.8▼
The notes to these accounts (7 items: statements of assets and debts, cost breakdowns, rights and commitments) are not shown here.
Timeline · acts, filings and financial milestones
Next filing, fiscal year 2026, expected by
2025
30-10
NBB filing
Annual accounts filed
fiscal year 2025 · full schema
31-03
Financial
Liquidity times 9current ratio 29.39
Current ratio from 3.42 to 29.39; short-term debt falls from €1.01M to €103k.
2024
30-10
NBB filing
Annual accounts filed
fiscal year 2024 · full schema
2023
27-10
NBB filing
Annual accounts filed
fiscal year 2023 · full schema
2022
29-09
NBB filing
Annual accounts filed
fiscal year 2022 · full schema
31-03
Financial
Highest result since 2019net €514k ▲13.3%
Operating result €732k, net result €514k, both a record.
31-03
Financial
Equity above €2MEq €2.51M ▲25.7%
4 profitable years in a row build equity to €2.51M.
2021
08-10
NBB filing
Annual accounts filed
fiscal year 2021 · full schema
2020
30-10
NBB filing
Annual accounts filed
fiscal year 2020 · full schema
31-03
Financial
Weakest financial yearnet €291k ▼6.1%
Net result drops to €291k, the lowest in the series; recovery starts the following year.
31-03
Financial
Liquidity triplescurrent ratio 111.26
Current ratio from 36.57 to 111.26; short-term debt falls from €37k to €15k.
2019
29-10
NBB filing
Annual accounts filed
fiscal year 2019 · full schema
Show earlier events
2018
09-10
NBB filing
Annual accounts filed
fiscal year 2018 · micro schema
2017
05-10
NBB filing
Annual accounts filed
fiscal year 2017 · micro schema
2016
11-10
NBB filing
Annual accounts filed
fiscal year 2016 · full schema
Financial milestoneNBB filingFinancial milestones sit on the fiscal year-end date, not the filing date.
Directors · office · real estate
Directors
2 acts for this company are in the Belgian State Gazette, of which we have read 0. We have therefore not extracted its directors from those acts yet.
Location & real-estate footprint
Registered office, Evere · 2 establishment units since 2009
Cannot be placed on the map
This address could not be matched to a point in the Belgian address register (BOSA BEST). The address below comes straight from the Crossroads Bank.
J.B. Bauwensstraat 121140 EvereGround area
223 m²
Building footprint
99 m²
Volume, LiDAR
1,428 m³
Parcel 21910E0124/00W019, Brussels · tallest building 17.3 m, ±5 floors. Linked by address, not a title deed.
2 establishment units
J.B. Bauwensstraat 12, 1140 Evere
since 20092.183.900.659
Van Ooststraat 28, 1030 Schaarbeek
since 20192.293.694.464
1 parcel
Brussels
1
(100%)
| Parcel (capakey) | Region | Area | Buildings | Height / fl. |
|---|---|---|---|---|
| 21910E0124/00W019 | Brussels | 223 m² | 1 · 99 m² | 17.2 m · 5 fl. |
Linked by address, not proof of ownership
Methodology
via establishment units: 1
1 of 1 parcel with an exact address match; the rest are indicative.
Linked through address data, this is not proof of ownership.
Recognitions · licences · registrations
Legal Entity Identifier
8755005TG5JOSUEZRS82
Similar companies · same sector, comparable size
MEDISCH KABINET DOKTER FREDERIX
BE 0887.193.474
Leopoldsburg · Eq €2.94M
DR. TERMOTE
BE 0446.729.243
Brecht · Eq €2.92M
WIJKGEZONDHEIDSCENTRUM ZUIDRAND
BE 0823.683.517
Antwerpen · Eq €3.00M
Maison médicale Le Gué
BE 0443.272.578
Tournai · Eq €2.89M
MEDI MAN
BE 0882.985.456
Namur · Eq €2.88M
Of 9,124 companies in sector 86210 we hold annual accounts for 6,337. 2,266 are within a factor 10 of this equity. The 5 above are the closest to it. See the whole sector
Company data · Crossroads Bank
Identification
Legal formPrivate limited company (pre-2019)
Founded18-09-2009
Fiscal year end31-03
Activities, NACEBEL 2025
86210General medical practice
Sources
Crossroads Bank for EnterprisesNational Bank · 15 filingsAddress and cadastre registers
Scores and ratios are computed by Checked and are not a credit decision.